Screener
Asset Entities ASST Medical Device — Loss on Debt Extinguishment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Other income | 955 | 252 |
| Interest expense on long-term notes payable, at fair value | (40) | — |
| Change in fair value on long-term notes payable, at fair value | (299) | — |
| Gain on extinguishment of debt | 30 | — |
| Transaction costs | — | (5,437) |
| Total other income/(expense) | 646 | (5,185) |
| Net loss before income taxes | (257,603) | (8,875) |
| Income tax benefit/(expense) | — | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — loss on debt extinguishment?
- Asset Entities (ASST) reported medical device — loss on debt extinguishment of $0 in Q2 2026.
- What does medical device — loss on debt extinguishment mean?
- Indicates the financial loss incurred when the medical device segment retires debt obligations before their scheduled maturity date. This is often a non-recurring expense that reflects strategic capital structure adjustments.
Ask your AI about Asset Entities's medical device — loss on debt extinguishment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude